Artha Sootra - Company Dashboard

Governance Classic Home

Piramal Pharma LtdPharmaceuticalsINE0DK501011Consolidated₹237.80+3.95 (+1.69%)

Valuation

Market Cap₹31.65K Cr

TTM PE-150.48x

Forward PE-324.22x

PEG4.51

Book Value₹61.16

P/B3.89x

TTM EPS₹-1.58

Fwd EPS₹-0.73

TTM Revenue₹9.78K Cr

TTM PAT₹-209.37 Cr

TTM EBITDA₹1.20K Cr

TTM EBIT₹312.36 Cr

Last Qtr PAT₹5.03 Cr

Last Qtr EBITDA₹348.74 Cr

Last Qtr EBIT₹115.59 Cr

Profitability

ROE-2.57%

ROCE2.22%

TTM NPM-2.14%

TTM EBITDA %12.27%

Curr OPM0.19%

Last OPM-2.94%

Curr NPM—

Last NPM—

Curr EPS₹0.04

Last EPS₹-0.52

Balance sheet

Equity₹1,328.39 Cr

Reserve₹6.81K Cr

Total Debt₹5,808.28 Cr

D/E0.71x

Interest %1742.15%

Curr Interest₹87.63 Cr

Price / range

Close₹237.76

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.74%

1W+2.15%

1M+20.25%

3M+17.49%

6M+48.35%

1Y+18.58%

2Y-13.78%

3Y+126.98%

5Y—

Diwali+39.94%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	1,345.38+19.3%	1,124.95	1,489.06	1,195.81	1,127.26	4,782.01
Other Income	137.93	114.63	183.69	96.15	201.97	662.73
Total Income	1,483.31+11.6%	1,239.58	1,672.75	1,291.96	1,329.23	5,444.74
Interest	17.27	16.36	19.50	16.84	20.38	79.95
Expenditure	-1,258.71-16.4%	-1,090.10	-1,275.33	-1,110.09	-1,081.82	-4,475.46
PBDT	0	0	0	0	0	0
EBITDA	171.50+35.0%	116.94	303.35	167.25	127.07	642
Depreciation	-67.56	-65.73	-70.12	-64.69	-61.25	-255.50
EBIT	103.94+57.9%	51.21	233.23	102.56	65.82	386.50
PBT	224.60-9.2%	149.48	331.85	154.93	247.41	876.77
Tax	-53.86	-36	-70.22	-26.02	-51.08	-176.76
Equity	1,328.39	1,327.35	1,327.16	1,325.83	0	1,327.16
OPM	15.14	12.06	19.84	11.99	21.95	16.10
Net Profit	170.74-13.0%	113.48	261.63	128.91	196.33	700.01
NPM	11.51	9.15	15.64	9.98	17.42	12.86
EPS	1.29-12.8%	0.85	1.97	0.97	1.48	5.28

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	4,782.01-9.5%	5,285.71+20.4%	4,390.11+27.5%	3,443.22
Other Income	662.73	207.35	202.06	341.07
Total Income	5,444.74-0.9%	5,493.06+19.6%	4,592.17+21.3%	3,784.29
Expenditure	-4,475.46+2.3%	-4,581.92-12.2%	-4,084.55-11.8%	-3,653.64
Interest	-79.95	-114.56	-107.10	-115.87
PBDT	0	0	0	0
EBITDA	642-38.3%	1,040.44+68.4%	617.92+533.6%	97.53
Depreciation	-255.50	-222.09	-205.26	-192.08
EBIT	386.50-52.8%	818.35+98.3%	412.66+536.4%	-94.55
PBT	876.77-3.8%	911.14+79.5%	507.62+310.4%	123.69
Tax	-176.76	-219.74	-116.40	-54.19
Equity	1,327.16	1,324.35	0	0
OPM (%)	16.10	16.59	11.00	3.00
Net Profit	700.01+1.2%	691.40+76.7%	391.22+462.9%	69.50
NPM (%)	12.86	12.59	9.00	2.00
EPS (Rs)	5.28+1.1%	5.22+71.1%	3.05+425.9%	0.58
CEPS	5.25	5.20	3.05	0.58

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	2,617.06+28.1%	2,269.92	2,751.77	2,139.87	2,043.72	8,869.08
Other Income	35.93	89.41	46.06	43.24	65.60	213.30
Total Income	2,652.99+25.8%	2,359.33	2,797.83	2,183.11	2,109.32	9,082.38
Interest	87.63	88.08	82.99	89.24	82.42	340.80
Expenditure	-2,589.10-19.3%	-2,386.35	-2,592.63	-2,246.12	-2,170.29	-9,119.50
PBDT	0	0	0	0	0	0
EBITDA	348.74+119.8%	195.20	460.51	195.73	158.69	921.62
Depreciation	-233.15	-223.55	-218.38	-212.74	-202.84	-831.24
EBIT	115.59+361.8%	-28.35	242.13	-17.01	-44.15	90.38
PBT	63.89	-27.02	29.43	-104.12	0	-233.26
Tax	-76.60	-61.93	-51.83	-42.33	-53.04	-149.88
Equity	1,328.39	1,327.35	1,327.16	1,325.83	0	1,327.16
OPM	2.41	-1.15	1.05	-4.77	0.00	-2.57
Net Profit	5.03+105.1%	-69.39	-8.82	-136.19	-99.22	-325.94
NPM	0.19	-2.94	-0.32	-6.24	-4.70	-3.59
EPS	0.04+105.3%	-0.52	-0.07	-1.03	-0.75	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	8,869.08-3.1%	9,151.18+12.0%	8,171.16+15.4%	7,081.55
Other Income	213.30	134.81	175.39	225.11
Total Income	9,082.38-2.2%	9,285.99+11.3%	8,346.55+14.2%	7,306.66
Expenditure	-9,119.50-2.0%	-8,944.28-9.6%	-8,163.96-9.2%	-7,474.18
Interest	-340.80	-421.59	-448.49	-344.18
PBDT	0	0	0	0
EBITDA	921.62-36.2%	1,444.83+20.8%	1,196.26+90.4%	628.24
Depreciation	-831.24	-816.34	-740.57	-676.69
EBIT	90.38-85.6%	628.49+37.9%	455.69+1040.5%	-48.45
PBT	-233.26-168.3%	341.71+185.2%	119.80+168.7%	-174.48
Tax	-149.88	-323.51	-161.47	-66.31
Equity	1,327.16	1,324.35	0	0
OPM (%)	-2.57	3.68	1.44	-2.39
Net Profit	-325.94-457.7%	91.13+411.4%	17.82+109.6%	-186.46
NPM (%)	-3.59	0.98	0.21	-2.55
EPS (Rs)	0-100.0%	0.69+392.9%	0.14+108.9%	-1.57
CEPS	0	0.68	0.14	-1.57

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	0.14	16 Jul 2025
2024	Final Dividend	0.11	12 Jul 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split